Literature DB >> 18514346

Mutations at nucleotides 573 and 579 within 5'-untranslated region augment the virulence of coxsackievirus B1.

Zhaohua Zhong1, Xiaobo Li, Wenran Zhao, Lei Tong, Jian Liu, Shuaiqin Wu, Lexun Lin, Zhonghai Zhang, Ye Tian, Fengmin Zhang.   

Abstract

Two mutants of coxsackievirus B1 (CVB1), CVB1c and CVB1e, with mutations in the stem-loop H of 5'-UTR were generated by site-directed mutagenesis. The A at nt579 of CVB1c was substituted by G. The U at nt573 and A at nt579 of CVB1e were substituted by A and G. The virulences of these mutants had been assessed by means of cytopathic effect (CPE), plaque formation, one-step growth curve, and 50% lethal dose (LD50) assays. The pathogenesis of these mutants was evaluated by attacking suckling Balb/c mice. Plaque assay and one-step growth curve showed that the replication of CVB1c and CVB1e on HeLa cells was significantly faster than that of their prototype CVB1n. Data of CPE assay, LD50, and pathological examination showed that CVB1c and CVB1e were more virulent than CVB1n. These data showed that mutation at nt579 (A-->G) alone and mutations at nt579 (A-->G) and nt573 (U-->A) together within 5'-UTR caused significant augment of the virulence and pathogenesis of coxsackievirus B1, and suggested that nt573 and nt579 might be molecular determinants for the virulence of coxsackievirus B1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514346     DOI: 10.1016/j.virusres.2008.04.012

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

1.  Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3.

Authors:  J D Burke; L C Platanias; E N Fish
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

2.  Molecular determinants of disease in coxsackievirus B1 murine infection.

Authors:  Javier O Cifuente; María F Ferrer; Carolina Jaquenod de Giusti; Wen-Chao Song; Víctor Romanowski; Susan L Hafenstein; Ricardo M Gómez
Journal:  J Med Virol       Date:  2011-09       Impact factor: 2.327

3.  Epidemics and aetiology of hand, foot and mouth disease in Xiamen, China, from 2008 to 2015.

Authors:  S Z He; M Y Chen; X R Xu; Q Yan; J J Niu; W H Wu; X S Su; S X Ge; S Y Zhang; N S Xia
Journal:  Epidemiol Infect       Date:  2017-04-03       Impact factor: 4.434

4.  A functional nuclear localization sequence in the VP1 capsid protein of coxsackievirus B3.

Authors:  Tianying Wang; Bohai Yu; Lexun Lin; Xia Zhai; Yelu Han; Ying Qin; Zhiwei Guo; Shuo Wu; Xiaoyan Zhong; Yan Wang; Lei Tong; Fengmin Zhang; Xiaoning Si; Wenran Zhao; Zhaohua Zhong
Journal:  Virology       Date:  2012-09-23       Impact factor: 3.616

5.  MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence.

Authors:  Lei Tong; Lexun Lin; Shuo Wu; Zhiwei Guo; Tianying Wang; Ying Qin; Ruixue Wang; Xiaoyan Zhong; Xia Wu; Yan Wang; Tian Luan; Qiang Wang; Yunxia Li; Xiaofeng Chen; Fengmin Zhang; Wenran Zhao; Zhaohua Zhong
Journal:  Nucleic Acids Res       Date:  2013-02-06       Impact factor: 16.971

6.  Curcumin inhibits the replication of enterovirus 71 in vitro.

Authors:  Ying Qin; Lexun Lin; Yang Chen; Shuo Wu; Xiaoning Si; Heng Wu; Xia Zhai; Yan Wang; Lei Tong; Bo Pan; Xiaoyan Zhong; Tianying Wang; Wenran Zhao; Zhaohua Zhong
Journal:  Acta Pharm Sin B       Date:  2014-07-24       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.